Skip to main content
Top

Varicose veins and venous thromboembolism in inflammatory rheumatic diseases: vascular complications and rehabilitation approaches

Published in:

Abstract

Inflammatory rheumatic diseases (IRDs) compromise vascular integrity through systemic inflammation and (auto) immune reactions, which are associated with an increased risk of vascular complications. Venous stasis, endothelial dysfunction, and coagulation imbalance are the primary pathophysiological factors behind thrombotic events in these individuals. The incidence of venous thromboembolism (VTE) in IRDs is higher than in the general population, although the magnitude of this increase varies across diseases. Inflammatory damage to vessel walls, diminished elasticity, and compromised muscle pump function may contribute to the formation of varicose veins (VVs). A sedentary lifestyle, decreased muscular strength, and weight gain worsen the condition, particularly by adversely affecting venous return in the lower extremities. Consequently, the prevention of vascular issues in IRDs should be facilitated by both pharmaceutical interventions and rehabilitation with lifestyle modifications. A multidisciplinary rehabilitation strategy—encompassing regular physical activity, compression therapy, inflammation management, weight control, and patient education—enhances venous return, mitigates thrombosis risk, and improves quality of life.
Title
Varicose veins and venous thromboembolism in inflammatory rheumatic diseases: vascular complications and rehabilitation approaches
Authors
Olena Zimba
Mariusz Korkosz
Anvar Sultanov
Bekzhan A. Permenov
Burhan Fatih Kocyigit
Publication date
02-02-2026
This content is only visible if you are logged in and have the appropriate permissions.

SLE: translating guidelines into practice (Link opens in a new window)

Equip yourself to confidently implement the latest evidence-based strategies for your patients with systemic lupus erythematosus with this program. Expert-led videos on topics including the updated EULAR 2023 guidelines available now.

Independent Medical Education Grant:
  • AstraZeneca
Learn more TODO (Link opens in a new window)

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video
Image Credits
Blood clot illustration/© Artur / Stock.adobe.com, Butterfly logo superimposed over silhouettes of people/© Springer Health+ IME, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI